Genmab Price to Sales Ratio 2009-2019 | GNMSF

Historical PS ratio values for Genmab (GNMSF) over the last 10 years. The current P/S ratio for Genmab as of February 28, 2020 is .
Genmab P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.343B $0.805B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $120.026B 13.72
CSL (CSLLY) Australia $93.989B 0.00
Gilead Sciences (GILD) United States $91.816B 11.83
Vertex Pharmaceuticals (VRTX) United States $57.895B 52.54
Biogen (BIIB) United States $53.974B 9.22
Regeneron Pharmaceuticals (REGN) United States $47.485B 20.11
Illumina (ILMN) United States $38.210B 39.50
Alexion Pharmaceuticals (ALXN) United States $20.389B 9.48
Seattle Genetics (SGEN) United States $18.657B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.001B 0.00
Incyte (INCY) United States $16.440B 35.27
BioMarin Pharmaceutical (BMRN) United States $16.134B 690.92
Galapagos (GLPG) Belgium $13.996B 30.57
Alnylam Pharmaceuticals (ALNY) United States $12.665B 0.00
Exact Sciences (EXAS) United States $11.959B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.059B 51.67
BeiGene (BGNE) Cayman Islands $9.466B 0.00
Moderna (MRNA) United States $8.804B 0.00
Sarepta Therapeutics (SRPT) United States $8.374B 0.00
QIAGEN (QGEN) Netherlands $8.224B 25.33
BioNTech SE (BNTX) Germany $7.666B 0.00
Bio-Techne Corp (TECH) United States $7.402B 50.66
Guardant Health (GH) United States $7.246B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.469B 17.12
Ascendis Pharma (ASND) Denmark $6.207B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Reata Pharmaceuticals (RETA) United States $5.712B 0.00
Exelixis (EXEL) United States $5.625B 18.06
ARGENX SE-ADR (ARGX) Netherlands $5.470B 0.00
Amarin (AMRN) Ireland $5.240B 0.00
Acceleron Pharma (XLRN) United States $4.595B 0.00
China Biologic Products (CBPO) China $4.538B 25.56
Repligen (RGEN) United States $4.484B 82.00
Global Blood Therapeutics (GBT) United States $3.720B 0.00
Bluebird Bio (BLUE) United States $3.714B 0.00
Mirati Therapeutics (MRTX) United States $3.670B 0.00
Adaptive Biotechnologies (ADPT) United States $3.577B 0.00
MorphoSys AG (MOR) Germany $3.452B 0.00
Zai Lab (ZLAB) China $3.253B 0.00
Alkermes (ALKS) Ireland $3.097B 245.38
Ultragenyx Pharmaceutical (RARE) United States $3.076B 0.00
Immunomedics (IMMU) United States $3.029B 0.00
Genmab (GMAB) Denmark $3.010B 11.81
CRISPR Therapeutics AG (CRSP) Switzerland $3.008B 50.97
Blueprint Medicines (BPMC) United States $2.938B 0.00
Emergent Biosolutions (EBS) United States $2.877B 19.97
NeoGenomics (NEO) United States $2.872B 125.04
MyoKardia (MYOK) United States $2.842B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.810B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.805B 0.00
Halozyme Therapeutics (HALO) United States $2.802B 0.00
Amicus Therapeutics (FOLD) United States $2.379B 0.00
UniQure (QURE) Netherlands $2.260B 0.00
Arena Pharmaceuticals (ARNA) United States $2.210B 5.77
RA PHARMCTL INC (RARX) United States $2.193B 0.00
Fate Therapeutics (FATE) United States $2.176B 0.00
Insmed (INSM) United States $2.173B 0.00
Principia Biopharma (PRNB) United States $2.068B 0.00
Eidos Therapeutics (EIDX) United States $1.887B 0.00
Epizyme (EPZM) United States $1.864B 0.00
Denali Therapeutics (DNLI) United States $1.827B 0.00
Ligand Pharmaceuticals (LGND) United States $1.815B 53.01
Alector (ALEC) United States $1.785B 0.00
Arvinas (ARVN) United States $1.599B 0.00
Zymeworks (ZYME) Canada $1.564B 0.00
Akcea Therapeutics (AKCA) United States $1.538B 35.61
REGENXBIO (RGNX) United States $1.505B 0.00
Coherus BioSciences (CHRS) United States $1.346B 16.13
Dicerna Pharmaceuticals (DRNA) United States $1.328B 0.00
Revance Therapeutics (RVNC) United States $1.317B 0.00
Myriad Genetics (MYGN) United States $1.288B 22.74
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Zealand Pharma (ZEAL) Denmark $1.255B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.220B 0.00
Editas Medicine (EDIT) United States $1.151B 0.00
Intra-Cellular Therapies (ITCI) United States $1.135B 0.00
Twist Bioscience (TWST) United States $1.073B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.026B 0.00
Athenex (ATNX) United States $0.972B 0.00
PHARMA MAR SA (PHMMF) Spain $0.932B 0.00
DBV Technologies S.A (DBVT) France $0.912B 0.00
Mesoblast (MESO) Australia $0.859B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Cytokineticsorporated (CYTK) United States $0.824B 0.00
Adverum Biotechnologies (ADVM) United States $0.805B 0.00
Codexis (CDXS) United States $0.777B 0.00
Sangamo Therapeutics (SGMO) United States $0.773B 0.00
Heska (HSKA) United States $0.764B 0.00
Vericel (VCEL) United States $0.675B 100.07
Cellectis S.A (CLLS) France $0.672B 0.00
Arcus Biosciences (RCUS) United States $0.661B 0.00
Retrophin (RTRX) United States $0.647B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.614B 0.00
Intrexon (PGEN) United States $0.605B 0.00
GENFIT S.A (GNFT) France $0.595B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.19
Anika Therapeutics (ANIK) United States $0.587B 20.06
ANI Pharmaceuticals (ANIP) United States $0.583B 10.53
Kadmon Holdings (KDMN) United States $0.578B 0.00
Intellia Therapeutics (NTLA) United States $0.568B 0.00
UROGEN PHARMA (URGN) United States $0.559B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.541B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.519B 0.00
Bellus Health (BLU) Canada $0.509B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 11.08
Compugen (CGEN) Israel $0.465B 0.00
NantKwest (NK) United States $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Inovio Pharmaceuticals (INO) United States $0.442B 0.00
BioDelivery Sciences (BDSI) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Mersana Therapeutics (MRSN) United States $0.419B 0.00
Cue Biopharma (CUE) United States $0.410B 0.00
Cel-Sci (CVM) United States $0.399B 0.00
AnaptysBio (ANAB) United States $0.396B 0.00
Merus (MRUS) Netherlands $0.392B 0.00
Puma Biotechnology (PBYI) United States $0.391B 0.00
Precision BioSciences (DTIL) United States $0.389B 0.00
PDL BioPharma (PDLI) United States $0.386B 9.66
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
Pfenex (PFNX) United States $0.380B 0.00
Novavax (NVAX) United States $0.379B 0.00
Kindred Biosciences (KIN) United States $0.378B 0.00
Clovis Oncology (CLVS) United States $0.375B 0.00
Agenus (AGEN) United States $0.367B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.358B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.345B 0.00
Dynavax Technologies (DVAX) United States $0.340B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Cellular Biomedicine (CBMG) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.303B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.294B 2.04
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
Stemline Therapeutics (STML) United States $0.290B 0.00
Albireo Pharma (ALBO) United States $0.288B 0.00
Syros Pharmaceuticals (SYRS) United States $0.282B 0.00
MannKind (MNKD) United States $0.278B 0.00
OSMOTICA PHARM (OSMT) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.269B 0.00
Kamada (KMDA) Israel $0.264B 10.96
Starpharma Holdings (SPHRY) Australia $0.257B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.256B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.247B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.239B 0.00
VBI Vaccines (VBIV) United States $0.234B 0.00
IVERIC Bio (ISEE) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.216B 0.00
Sutro Biopharma (STRO) United States $0.213B 0.00
Protagonist Therapeutics (PTGX) United States $0.213B 0.00
XOMA (XOMA) United States $0.208B 0.00
Geron (GERN) United States $0.208B 0.00
Alcobra (ARCT) United States $0.204B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
VTv Therapeutics (VTVT) United States $0.203B 0.00
Prometic Life Sciences (LMNL) Canada $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.194B 0.00
Arbutus Biopharma (ABUS) Canada $0.193B 0.00
Athersys (ATHX) United States $0.188B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
Affimed (AFMD) Germany $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Exicure (XCUR) United States $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.160B 8.23
Dyadic (DYAI) United States $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
Selecta Biosciences (SELB) United States $0.153B 0.00
Fortress Biotech (FBIO) United States $0.151B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Verastem (VSTM) United States $0.142B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.139B 0.00
Aptinyx (APTX) United States $0.137B 0.00
VolitionRX (VNRX) Singapore $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
CorMedix Inc (CRMD) United States $0.133B 0.00
Arsanis (XFOR) United States $0.132B 0.00
Happiness Biotech Group (HAPP) China $0.129B 0.00
ARAVIVE, INC (ARAV) United States $0.128B 0.00
PHASEBIO PHARMA (PHAS) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.107B 0.00
Palatin Technologies (PTN) United States $0.106B 2.89
OvaScience (MLND) United States $0.104B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Prima BioMed (IMMP) Australia $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Adocia (ADOCY) France $0.086B 0.00
Applied Genetic Technologies (AGTC) United States $0.085B 0.00
Proteostasis Therapeutics (PTI) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 4.29
Menlo Therapeutics (MNLO) United States $0.066B 0.00
IBio (IBIO) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Acorda Therapeutics (ACOR) United States $0.064B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Trevena (TRVN) United States $0.061B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Curis (CRIS) United States $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
TOCAGEN INC (TOCA) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.024B 0.00
Oncobiologics (OTLK) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.003B 0.00